SUPPLY OF EVEROLIMUS DRUG-ELUTING STENT HDFRZ

This tender concerns the supply of Everolimus drug-eluting stents for HDFRZ (likely Hospital de Fray Bentos or a similar medical institution). The procurement aims to acquire high-quality cardiovascular implants essential for interventional cardiology procedures. Everolimus drug-eluting stents are designed to release medication over time, preventing restenosis (re-narrowing of the artery) after angioplasty. Bidders are expected to supply stents that meet stringent international medical device standards and regulatory requirements. The tender will likely specify the types, sizes, and quantities of stents required, as well as delivery timelines and storage conditions. Evaluation criteria will focus on the quality and proven efficacy of the stents, the reputation and reliability of the supplier, compliance with regulatory approvals (e.g., CE marking, FDA approval), and competitive pricing. This procurement is critical for ensuring that HDFRZ has access to advanced medical technology to treat patients with coronary artery disease, thereby improving patient outcomes and reducing the need for repeat interventions. The successful supplier will be a key partner in delivering advanced cardiac care.

This is a services contract in the health and medical services, information and communication technology and general supplies sectors. Located in Chile, Latin America, this opportunity is open to firms and consortiums.

Published through Chile Mercado Publico, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for services in the health and medical services sector. Service contracts are typically evaluated on both technical quality and price, and may require bidders to demonstrate relevant experience and qualified personnel. This contract has already been awarded. The information is published for transparency and market intelligence purposes.